The History of DIAMED Medizintechnik
The vision of improving and preserving lives has driven our company founder Hans Karl Stock for his entire life. In this spirit he created and established DIAMED, passing his passion and dedication on to his employees and to the next generation.Then and now, through our close cooperation with physicians and medical specialists, we learn about and experience patients’ personal stories. These deeply touching fates increase our motivation and drive to develop life-improving and life-saving therapeutic solutions in extracorporeal blood purification.
'Know-how and passion for health' – for DIAMED this also means ensuring medical care for all patients. Again and again, the rapid delivery of equipment and medical devices has had life-saving consequences. Being able to provide flexible support in acute situations and thus saving lives, we have always been maintaining a four to six-month supply of critical medical devices in our main warehouse in Cologne since our founding. Whether the 2011 E. coli outbreak in Northern Germany, the 2012 severe earthquake in Italy, resulting in a supply bottleneck from a German provider, or today's coronavirus pandemic: we are providing fast and flexible support – yesterday, today, and tomorrow.
DIAMED Medizintechnik milestones
With the founding of DIAMED in Cologne, entrepreneur Hans Karl Stock laid the cornerstone for our company. The close cooperation with our Japanese partner Asahi Kasei Medical Co. in dialysis, therapeutic apheresis, and continual renal replacement therapy that has started in these early days is being successfully continued by the second generation to this day.
Opportunities to realize and further develop extracorporeal blood purification have always driven DIAMED. To promote international professional discussions and knowledge transfer, we established the 'First World Congress of Plasma Therapy'. In 1980, specialists from around the world came to Cologne to discuss ongoing developments in therapeutic apheresis.
of the BTS 100
For us, the highest quality of our equipment is essential. The market introduction of the BTS 100 for LDL apheresis and immunoadsorption was groundbreaking.
With the Hemomat/Plasmomat, DIAMED Medizintechnik introduced the first 'stand-alone' device for plasma exchange, immunoadsorption and lipid apheresis for the German market.
multifunctional device:
Octo Nova
In 2000, we introduced Octo Nova, designed and developed by DIAMED, the world’s first multifunctional device for continuous hemofiltration and therapeutic apheresis. In Germany, the Octo Nova was the first device to offer automated citrate anticoagulation, which today is standard procedure.
In 2011, the advisory board, consisting of family members and external experts, was established and is advising and supporting the further development of DIAMED Medizintechnik.
Through the introduction of the Asahi Plasauto SIGMA to the German, Swiss and Austrian markets for all procedures in continuous renal replacement therapy and selective therapeutic apheresis treatments, hospitals could now provide a variety of extracorporeal treatments by using one single device. Today, Plasauto SIGMA is the market leader in pediatrics and is used in numerous maximum care hospitals throughout Germany.
The large multi-center study Pro(a)-LiFe, initiated by DIAMED, verified the clinical efficacy of lipoprotein apheresis in patients with increased Lipoprotein(a) and documented progression of arteriosclerosis. In 2013, this study was featured prominently in the cardiology journal Circulation.
In 2014, the next generation of the Stock family has taken over responsibility and continues to lead DIAMED as laid out by the founder, 'pro health with know-how and passion'.
Forty-four years after our founding, we have relaunched our brand identity with a contemporary corporate design, a new logo, and our new claim: 'Know-how and passion for health.' This claim is expressed not only through our daily work but also visually reinforced with our heart image.
A new market is opened up with the Netherlands. Here, too, we act with our claim 'Preserving life is what drives us' and want to set new standards with regard to our already very successful and established therapy solutions. A new chapter for DIAMED Medizintechnik.